We are live on ! Find out more
Vanguard Capital Management

Vanguard Capital Management Portfolio holdings

AUM $4.68T
This Fund
S&P 500
This Quarter Est. Return
+26.64%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$4.68T
AUM Growth
+$637B
Cap. Flow
+$33.9B
Cap. Flow %
0.72%
Top 10 Hldgs %
32.56%
Holding
4,163
New
101
Increased
2,575
Reduced
1,196
Closed
71

Top Sells

Rank Stock Value
1
HON icon
Honeywell
HON
+$4.59B
2
CTRA
Coterra Energy
CTRA
+$1.69B
3
CRM icon
Salesforce
CRM
+$1.28B
4
JPM icon
JPMorgan Chase
JPM
+$1.15B
5
HOLX
Hologic
HOLX
+$1.1B

Sector Composition

Rank Sector Weight
1 Technology 36.14%
2 Financials 12.19%
3 Industrials 9.6%
4 Healthcare 9.39%
5 Consumer Discretionary 9.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XTNT icon
3626
Xtant Medical Holdings
XTNT
$47.2M
$848K ﹤0.01%
2,014,603
CHRN
3627
ChronoScale Holdings
CHRN
$3.09B
$835K ﹤0.01%
37,583
+3,551
+10% +$54.9K
DYAI icon
3628
Dyadic International
DYAI
$30.6M
$832K ﹤0.01%
928,233
EONR
3629
EON Resources
EONR
$25M
$822K ﹤0.01%
1,860,413
-46,513
-2% -$30.9K
ONMD icon
3630
OneMedNet
ONMD
$33.9M
$819K ﹤0.01%
1,152,210
+36,645
+3% +$30.4K
DLO icon
3631
dLocal
DLO
$4.03B
$819K ﹤0.01%
63,001
NTIP icon
3632
Network-1 Technologies
NTIP
$34.8M
$813K ﹤0.01%
553,311
+51,377
+10% +$75.3K
MNOV icon
3633
MediciNova
MNOV
$66.4M
$804K ﹤0.01%
609,052
-1,987
-0.3% -$2.73K
INKT icon
3634
MiNK Therapeutics
INKT
$59.2M
$803K ﹤0.01%
68,660
+9,296
+16% +$108K
EEX
3635
DELISTED
Emerald Holding
EEX
$796K ﹤0.01%
157,879
-559
-0.4% -$2.72K
RAVE icon
3636
RAVE Restaurant Group
RAVE
$43.3M
$792K ﹤0.01%
242,298
+18,851
+8% +$53.5K
GRML
3637
Greenland Mines Ltd
GRML
$28.9M
$790K ﹤0.01%
3,038,347
+2,461,071
+426% +$912K
PRPL icon
3638
Purple Innovation
PRPL
$25.4M
$789K ﹤0.01%
88,420
-1,776
-2% -$21.8K
AHT
3639
Ashford Hospitality Trust
AHT
$21M
$787K ﹤0.01%
243,014
CIRC
3640
Circle8 Group
CIRC
$58.9M
$784K ﹤0.01%
852,036
+333,195
+64% +$526K
TXMD icon
3641
TherapeuticsMD
TXMD
$23.4M
$782K ﹤0.01%
353,697
MNTS icon
3642
Momentus
MNTS
$82.3M
$778K ﹤0.01%
115,779
+113,550
+5,094% +$913K
PPSI
3643
Pioneer Power Solutions
PPSI
$30.7M
$771K ﹤0.01%
195,788
-349
-0.2% -$1.37K
KOSS icon
3644
Koss Corp
KOSS
$34.3M
$760K ﹤0.01%
189,607
NEUP
3645
Neuphoria Therapeutics
NEUP
$21.6M
$758K ﹤0.01%
173,488
+74,972
+76% +$362K
BAFN icon
3646
BayFirst Financial Corp
BAFN
$167M
$754K ﹤0.01%
150,806
+2,171
+1% +$13.9K
FTHM icon
3647
Fathom Holdings
FTHM
$24.2M
$740K ﹤0.01%
732,186
+9,600
+1% +$7.52K
TLPH icon
3648
Talphera
TLPH
$62.8M
$723K ﹤0.01%
701,877
+260,266
+59% +$222K
FRBT
3649
Forbright Inc
FRBT
$947M
$718K ﹤0.01%
+39,239
New +$711K
CTSO icon
3650
Cytosorbents Corp
CTSO
$23.9M
$716K ﹤0.01%
1,914,063
+34,074
+2% +$18K

Similar funds

Vanguard Capital Management's Q2 2026 Portfolio in Review

As of Q2 2026, Vanguard Capital Management held 4,163 positions worth $4.68T, up 16% from $4.04T the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Trading was light in Q2 2026: portfolio turnover was 4.1%. Vanguard Capital Management opened 101 new positions and exited 71, leaving the 4,163-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 31% a quarter earlier, followed by Financials and Industrials.

  • Vanguard Capital Management's largest Q2 2026 buy was Honeywell Aerospace: 20,693,166 shares worth $4.57B.
  • Vanguard Capital Management added most to Marvell Technology in Q2 2026, an estimated $3.77B increase.
  • Vanguard Capital Management's biggest Q2 2026 reduction was Honeywell, cutting an estimated $4.59B.
  • Vanguard Capital Management fully exited Coterra Energy in Q2 2026, selling an estimated $1.69B.
  • Vanguard Capital Management's ten largest holdings make up 33% of its $4.68T portfolio in Q2 2026.
  • Vanguard Capital Management opened 101 new positions and closed 71 in Q2 2026.
  • Vanguard Capital Management's portfolio value rose 16% quarter-over-quarter to $4.68T.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.